CIPH β€” CIPHERGEN BIOSYSTEMS INC COM

Ownership history in UBS AG  Β·  7 quarters on record

This page tracks every 13F SEC filing in which UBS AG reported a position in CIPHERGEN BIOSYSTEMS INC COM (CIPH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

% of Fund (quarterly)
πŸ“‹ Quarterly Holdings History 7 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2007 Q2 REDUCED 2 -78 -97.5% 0.00% $9 β€”
2006 Q4 ADDED 80 +23 +40.4% 0.00% $17 β€”
2006 Q3 REDUCED 57 -1 -1.7% 0.00% $19 β€”
2006 Q1 REDUCED 58 -1,579 -96.5% 0.00% $5 β€”
2005 Q4 ADDED 1,637 +1,636 +163600.0% 0.00% $2K β€”
2005 Q3 REDUCED 1 -6,722 -100.0% 0.00% $1 β€”
2005 Q2 INITIATED 6,723 β€” β€” 0.00% $13K β€”

🏒 Other funds also holding CIPH

As of 2007 Q2 β€” sorted by position size

SCHAPER BENZ & WISE INVESTMENT COUNSEL INC/WI 3Y 7Y 0.03% VANGUARD GROUP INC 3Y 7Y 0.0% FEDERATED HERMES, INC. 3Y 7Y 0.0% WELCH & FORBES LLC 3Y 7Y 0.0% WELLINGTON MANAGEMENT GROUP LLP 3Y 7Y 0.0% DIMENSIONAL FUND ADVISORS LP 3Y 7Y 0.0% D. E. Shaw & Co., Inc. 3Y 7Y 0.0% RBC Capital Markets, LLC 3Y 7Y 0.0% BARCLAYS PLC 3Y 7Y 0.0% GEODE CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0%
← Back to UBS AG Holdings